Publications by authors named "Mario Bazzan"

Claim this Profile
[
[Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores.].
Laura M Cavagna, Mario Bazzan

Recenti Prog Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid Antibodies and Infection: .
Savino Sciascia, Massimo Radin, Mario Bazzan, Barbara Montaruli, Domenico Cosseddu

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay.
Barbara Montaruli, Chiara Novelli, Laura Solfietti, Alessandra Valpreda, Mario Bazzan

Int J Lab Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
Savino Sciascia, Massimo Radin, Irene Cecchi, Maria Laura Bertolaccini, Maria Tiziana Bertero, Mario Bazzan

Rheumatology (Oxford)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome.
Mario Bazzan, Tullia Todros, Silvana Tedeschi, Gianluigi Ardissino, Simona Cardaropoli

Thromb Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al.
Massimo Radin, Savino Sciascia, Mario Bazzan, Tiziana Bertero, Renato Carignola

Arthritis Rheumatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients.
Mario Bazzan, Barbara Montaruli, Savino Sciascia, Domenico Cosseddu, Claudio Norbiato

Intern Emerg Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome.
Savino Sciascia, Massimo Radin, Irene Cecchi, Elena Rubini, Mario Bazzan

Semin Arthritis Rheum· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid antibodies: crossroads between autoimmunity and infections?
Savino Sciascia, Massimo Radin, Mario Bazzan, Dario Roccatello

Intern Emerg Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.
Dario Roccatello, Savino Sciascia, Daniela Rossi, Carla Naretto, Mario Bazzan

BMJ Open· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.
Raffaele Pesavento, Lucia Filippi, Antonio Palla, Adriana Visonà, Carlo Bova, Mario Bazzan

Eur Respir J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute renal infarction: a single center experience.
Paola Mesiano, Cristiana Rollino, Giulietta Beltrame, Michela Ferro, Giacomo Quattrocchio, Mario Bazzan

J Nephrol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome.
Savino Sciascia, Massimo Radin, Mario Bazzan, Dario Roccatello

Intern Emerg Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin generation assay: interactions between chronic inflammation and haemostasis in patients with autoimmune diseases.
Laura Solfietti, Giovanni B Binello, Stefania Stella, Mario Bazzan, Milena Salierno

Clin Exp Rheumatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy.
Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan

Mediterr J Hematol Infect Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic lupus erythematosus and thrombosis.
Mario Bazzan, Antonella Vaccarino, Fabio Marletto

Thromb J· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis.
Walter Ageno, Francesco Dentali, Valerio De Stefano, Stefano Barco, Teresa Lerede, Mario Bazzan

Thromb Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
8
8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study.
Savino Sciascia, Dario Roccatello, Maria Tiziana Bertero, Debora Di Simone, Domenico Cosseddu, Mario Bazzan

Inflamm Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs.
Elena Crisà, Ermanno Venturino, Roberto Passera, Marco Prina, Piercarla Schinco, Mario Bazzan

Ann Hematol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study.
Mario Bazzan, Barbara Montaruli, Antonella Vaccarino, Gianni Fornari, Maddalena Saitta

Intern Emerg Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
Maria Rita Taliani, Cecilia Becattini, Giancarlo Agnelli, Paolo Prandoni, Marco Moia, Mario Bazzan

Thromb Haemost· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients.
Mario Bazzan, Antonella Vaccarino

Intern Emerg Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.
Melina Verso, Giancarlo Agnelli, Pieter W Kamphuisen, Walter Ageno, Mario Bazzan

Intern Emerg Med· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Eugenia Rota, Mario Bazzan, Giovanni Fantino

Thromb Haemost· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoproliferative disease of the orbit.
Francesco P Bernardini, Mario Bazzan

Curr Opin Ophthalmol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis